Digital solutions for self-management of health, which in many cases have been developed by young companies and start-ups, have led to rapid development in health care. All possibilities of digitalization are slowly being realized. At the same time, innovations must not become isolated solutions, because interdisciplinarity and interoperability are necessary. Under the keyword Digital Health or E-Health, one can find digital solution approaches of start-ups that support patients in applications, treatments, care and support with the possibilities of modern information and communication technologies. Prevention, diagnosis and therapy can be better implemented through tailor-made digital solutions, but also digital therapy assistants, which would not be possible without intelligent use of Big Data and AI. Some of the young companies mentioned here have already successfully attempted to establish the products and services they are developing as cash benefits:
- Neolexon from plant 1 in Munich has developed apps for people with speech disorders after brain damage to make their work easier for therapists and those affected.
- 8sense is a startup from the Digital Founder Centre in Rosenheim, which has developed virtual coaching systems to combat back pain. Feedback from the users of the platform encourages them to change their old behaviour patterns.
- Visionhealth is dedicated to digital therapy support for patients with respiratory diseases. The Kata platform uses an algorithm to detect the effectiveness and errors of inhalation.
- Temedica supports patients in their healing process, through digital therapy and prevention measures for various indications. Products of the company, which was founded in 2016, are already covered by health insurance today.
- M-sense is the first migraine and headache app that protects patients from drug abuse and is certified as a medical device in Germany. Due to the German Digital Supply Act, the product could be reimbursed by health insurance companies according to a doctor’s prescription.
- Inveox has developed a fast and reliable method for diagnosing cancer. A fully automated laboratory and structured communication between physicians and pathologists are possible in this way.
- Climedo stands for personalised cancer therapies. Digital assistants replace clinical studies in paper form.
- IT labs as an intelligent care management platform determine the demand for products for patients in the home care and medical aids market.
- Mercuris combines process optimisation, digital health and medical technology in one, as the online platform with industrial 3D printing helps orthopaedic technicians to produce CE-compliant orthoses and prostheses.
- The young company Plasmion with the new SICRIT technology stands for an extension of automated laboratory devices that can diagnose odours as „electronic nose“.
- Wellabe (formerly Bodylabs) can use an app to measure and evaluate 60 health values in a short time and discuss them. Prevention programs are then recommended to the user after evaluation.
- Numares, founded as a spin-off of the University of Regensburg, has achieved an economic breakthrough by using in-vitro test systems in clinics for diagnostic purposes. Blood and urine can be evaluated qualitatively and quantitatively.
- Ithera Medical is convincing in innovative imaging diagnostics because three-dimensional images in anatomy allow conclusions to be drawn about the development of tumors, for example.
- Nanotemper Technologies has a unique selling point because the development and production of laboratory measuring instruments in biophysics for basic and drug research are associated with a significant time saving of 142.5 hours. Only 1.5 hours! are required for the determination of biomolecular properties, as well as a 40 times smaller selection of materials in the test procedure.
- Dynamic Biosensors is engaged in the analysis of proteins in order to provide proof of the effectiveness of drugs so that diseases can be fought in a targeted and efficient enough way. The start-up is among the finalists in the 2010 business plan competition.
- The biopharmaceutical company Bicoll researches the development of active substances in plants and specializes in the discovery of new natural substances for cosmetics, pharmaceuticals and dietary supplements, etc.
- Chromotek as a life science start-up produces products from the portfolio of biomedical and pharmaceutical research and intervenes early in the value chain in the pharmaceutical sector. Nano-antibodies of camel animals such as alpacas serves as multi-tools to which substances such as molecules and dyes, but also proteins and nucleic acids can be coupled.
Source: www.munich-startup.de